Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Pediatrics in Review
|
September 30, 2023
Rotavirus
Courtney A Nugent, David A Stewart
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 11, 2005
The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha
Joshua P Gray, John W Davis, Lakshmi Gopinathan, et al.
Toxicology and Applied Pharmacology
|
May 6, 2003
Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643
John P Vanden Heuvel, Dirk Kreder, Benjamin Belda, et al.
Clinical Pharmacology : Advances and Applications
|
October 23, 2015
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)
Lance A Wollenberg, Donald T Corson, Courtney A Nugent, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Pediatrics in Review
|
September 30, 2023
Rotavirus
Courtney A Nugent, David A Stewart
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 11, 2005
The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha
Joshua P Gray, John W Davis, Lakshmi Gopinathan, et al.
Toxicology and Applied Pharmacology
|
May 6, 2003
Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643
John P Vanden Heuvel, Dirk Kreder, Benjamin Belda, et al.
Clinical Pharmacology : Advances and Applications
|
October 23, 2015
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)
Lance A Wollenberg, Donald T Corson, Courtney A Nugent, et al.
Page
of 1